Additional Information
Market: LSE, NASDAQ
Sector: Semiconductors
EPIC: ARM
Latest Price: 816.75p  (-0.52% Descending)
52-week High: 1,112.00p
52-week Low: 778.50p
Market Cap: 11,482.84M
1 year chart
Deal ARM Tax Free*
*subject to change and depends on individual circumstances.
1 day chart
Advertisement
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
ARM Holdings
www.arm.com
Deal ARM Holdings Tax Free* Losses can exceed
your initial deposit
*subject to change and depends on individual circumstances.

ARM designs the technology that lies at the heart of advanced digital products, from wireless, networking and consumer entertainment solutions to imaging, automotive, security and storage devices.

ARM’s product offering includes 32-bit RISC microprocessors, graphics processors, enabling software, cell libraries, embedded memories ,...

Read more
Pdf

Brokers lower ARM as Apple runs out of juice

January 15 2013, 12:14pm Rumours have been circulating that Apple has cut in half its orders for iPhone 5 touch screens in the first quarter of 2013.

As investors fret that Apple (NASDAQ:AAPL) might be losing its touch, two brokers have cut their ratings for chip designer ARM (LON:ARM), a major beneficiary of Apple’s rise to prominence.

Morgan Stanley has cut its rating to ‘equal weight’ while bumping up its price target from 725p to 911p to take account of the share’s 45% rise over the last year.

It is not particularly worried about rumours that Apple is scaling back on orders for components of its iPhone 5, but it does believe that everything that could go right for ARM over the last 12 months pretty much has, and this is reflected in the share price.

“Everything we were hoping for 12 months ago is now taken for granted due to strong news flow, including the iPad mini launch, disappointing Ultrabook launch and weak PC sales. It will be difficult for news flow to improve from here, and ARM could still lose sockets here and there (Samsung Galaxy S4, for instance),” suggests Morgan Stanley.

The broker notes that the current price/earnings ratio (PER) is at about 44, which is at the high end of the ten-year range.

“While 12 months ago investors were worried about ARM’s position vs Intel, we believe the current share price implies a near perfect trajectory in ARM’s market share and royalty rate for the next two years,” Morgan Stanley argues.

Though it remains very impressed with the company, the advice to those not yet invested in ARM is to wait for a better entry price.

Potential share price catalysts, according to Morgan Stanley, include: Apple using ARM intellectual property in its personal computer (i.e. desktops & laptops, not tablets); Samsung switching back to Imagination Technologies (LON:IMG) for its graphics processing unit design; Intel’s new chief executive officer, whenever he or she is announced.

Investec is also now a holder, not a buyer, after the recent sharp increase in ARM’s share price.

It has raised its target price from 800p to 900p, having suggested in a research note in September last year that its royalty projections for ARM supported a 900p share price by 2016.

That price target assumed a number of things, including: a 90% share in the tablet market; a 20% share in the server market; Intel’s assault on the smartphone market failing to achieve market share above 10%.

“We see recent news flow cementing ARM’s likely success here, but for us to move beyond 900p requires upward moves in assumed chip volumes, royalty rates and stronger market share gains. While possible, we see it as too early to assume these as a base case,” Investec said.

As for Apple, rumours have been circulating that the company has cut in half its orders for iPhone 5 touch screens in the first quarter of 2013.

Japanese financial daily Nikkei reported that Apple’s order of 65mln iPhone 5 screens has been halved, citing sources from component suppliers. Apple’s touch screen providers are believed to be Sharp, LG Display and Japan Display.

Orders for other components have also been cut, suggesting that sales of the latest version of Apple’s cash cow have not been as buoyant as expected.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.